Dr Robert Popovian discusses access to immunization services among adults in low-income communities and efforts to expand pharmacists’ authority to administer vaccines to increase vaccination rates for this vulnerable population.
The agency has issued proposed draft recommendations to guide incorporation of cybersecurity protections into medical devices at the time of manufacture.
Studies show fecal microbiota transplantation (FMT) can help patients with ulcerative colitis (UC) achieve remission, but challenges must be addressed before FMT can become a standard of treatment for UC.
David Dickerson, MD, chair of the ASA Committee on Pain Medicine, discusses suggested changes and recommendations to the proposed clinical practice guidelines for prescribing opioids that were recently issued by the CDC.
Benajamin Lebwohl, MD, MS, and Shayna Coburn, PhD, discuss how clinicians can help patients with celiac disease find treatment for mental health disorders.
While food insecurity is a leading public health issue, research shows that nutrition security may be a better target for disease prevention strategies.
Cosby A. Stone, MD, and Brigid S. Boland, MD, discuss the controversy of administering live vaccines to infants who were exposed to TNFi during pregnancy and breastfeeding.
With youth suicides on the rise, the American Academy of Pediatrics and American Foundation for Suicide Prevention, in collaboration with experts from the National Institute of Mental Health (NIMH), created a document to support pediatric health clinicians.
The COVID-19 pandemic has underscored how easy it is for disreputable and non-authoritative sources to spread wrong and possibly dangerous medical information.
Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.
In this ninth update to the living guideline on COVID-19 therapeutics, the World Health Organization evaluates the use of nirmatrelvir/ritonavir for nonsevere COVID-19 and revises prior recommendations regarding the use of remdesivir.
Joseph J. Jennings, MD, and Cynthia L. Sears, MD, describe the systemic effects of H pylori infection and clinical approaches for treating the extragastric complications.
